CONCLUSIONS: Expression of activated LXR alpha blocks proliferation of human colorectal cancer cells and slows the growth of xenograft tumors in mice. It also reduces

intestinal tumor formation after administration of chemical carcinogens, and in Apc(min/+) mice. LXR agonists therefore might be developed as therapeutic treatments for colorectal cancer.”
“Aims Although several factors contribute to wound healing, bacterial infections and the presence of biofilm can significantly affect healing. Despite that this clearly indicates that therapies should address biofilm in wounds, only few wound care products have been evaluated for their antibiofilm effect. For this reason, find more we developed a rapid quantification approach to investigate

the efficacy of wound care products on wounds infected with Staphylococcus spp. Methods and Results An in vitro chronic wound infection model was used in which a fluorescent Staph.aureus strain was used to allow the rapid quantification of the bacterial burden after treatment. A good correlation was observed between the fluorescence signal and the bacterial counts. When evaluated in HDAC inhibitor review this model, several commonly used wound dressings and wound care products inhibited biofilm formation resulting in a decrease between one and seven log CFU per biofilm compared with biofilm formed in the absence of products. In contrast, most dressings only moderately affected mature biofilms. Conclusion Our model allowed the rapid quantification of the bacterial burden after treatment. However, the efficacy of treatment varied between the different types of

dressings and/or wound care products. Significance and Impact of the Study Our model can be used to compare the efficacy of wound care products to inhibit biofilm formation and/or eradicate mature biofilms. In addition, the results indicate that treatment of infected wounds should be started as soon as possible and that novel products with more potent antibiofilm activity are needed.”
“Duez H, Staels B. Rev-erb-alpha: an integrator of circadian rhythms and metabolism. J Appl Physiol 107: 1972-1980, 2009. First published August 20, 2009; doi:10.1152/japplphysiol.00570.2009.-The endogenous circadian clock ensures daily NVP-BSK805 molecular weight rhythms in diverse behavioral and physiological processes, including locomotor activity and sleep/wake cycles, but also food intake patterns. Circadian rhythms are generated by an internal clock system, which synchronizes these daily variations to the day/night alternance. In addition, circadian oscillations may be reset by the time of food availability in peripheral metabolic organs. Circadian rhythms are seen in many metabolic pathways (glucose and lipid metabolism, etc.) and endocrine secretions (insulin, etc.). As a consequence, misalignment of the internal timing system vs.